A detailed history of Diversified Trust CO transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Diversified Trust CO holds 71,803 shares of FOLD stock, worth $804,193. This represents 0.02% of its overall portfolio holdings.

Number of Shares
71,803
Previous 66,633 7.76%
Holding current value
$804,193
Previous $784,000 9.18%
% of portfolio
0.02%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$9.04 - $11.75 $46,736 - $60,747
5,170 Added 7.76%
71,803 $712,000
Q1 2024

Apr 18, 2024

BUY
$11.43 - $14.24 $45,011 - $56,077
3,938 Added 6.28%
66,633 $784,000
Q4 2023

Jan 08, 2024

BUY
$9.97 - $14.52 $46,191 - $67,271
4,633 Added 7.98%
62,695 $889,000
Q3 2023

Nov 17, 2023

BUY
$11.78 - $13.86 $212,617 - $250,159
18,049 Added 45.11%
58,062 $706,000
Q1 2023

Apr 07, 2023

BUY
$10.91 - $13.54 $20,052 - $24,886
1,838 Added 4.81%
40,013 $443,000
Q3 2022

Oct 14, 2022

SELL
$9.82 - $12.75 $18,176 - $23,600
-1,851 Reduced 4.62%
38,175 $399,000
Q2 2022

Jul 12, 2022

SELL
$6.23 - $11.12 $168 - $300
-27 Reduced 0.07%
40,026 $430,000
Q4 2021

Jan 13, 2022

BUY
$9.82 - $12.44 $27,761 - $35,167
2,827 Added 7.59%
40,053 $463,000
Q3 2021

Jan 13, 2022

SELL
$8.74 - $11.84 $2,219 - $3,007
-254 Reduced 0.68%
37,226 $356,000
Q2 2021

Jul 20, 2021

BUY
$8.71 - $10.72 $326,450 - $401,785
37,480 New
37,480 $361,000
Q4 2020

Jan 08, 2021

SELL
$13.47 - $24.89 $431,538 - $797,400
-32,037 Closed
0 $0
Q3 2020

Oct 15, 2020

SELL
$12.89 - $15.89 $211,035 - $260,151
-16,372 Reduced 33.82%
32,037 $452,000
Q2 2020

Jul 07, 2020

BUY
$8.86 - $15.69 $428,903 - $759,537
48,409 New
48,409 $730,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $3.14B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.